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Abstract
Mycobacterium tuberculosis resistant  strains is a matter of great concern for TB control Program since no 
cure for some   multi drug resistance TB (MDR-TB) cases.  These strains could spread around the world, make 
a great challenges for control measures.  Mycobacterium tuberculosis  strains resistance to anti  tuberculosis drugs 
is mainly caused by the alteration in several genes encoding the molecular targets. Mutation of katG at codon 
315 especially Ser315Thr are responsible for INH resistance in a large proportion of TB cases. The aim of this 
study is to  know the frequency of of  katG Ser315Thr of M. tuberculosis mutant and the pattern of resistance to 
Anti TB drugs. The study design  was observational laboratoric. Eighty fi ve M. tuberculosis INH resistant  clinical 
isolates  were screened for mutation of  katGSer315Thr by using PCR-RFLP and DNA sequence analysis.The 
results showed that katG Ser 315Thr were identifi ed  in 23 (27,05%) of INH resistance isolates.  Frequency of 
MDR among  the  katG Ser315Thr mutants almost double than the non mutant. The result suggested that the 
the  katG Ser315Thr mutation may play important role in the development of MDR-TB. 
Keywords: katG Ser315Thr Mycobacterium tuberculosis mutant, frequency, anti TB drugs, Multi Drug Resistant, 
pattern of resistance.
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Introduction
Despite the declaration of tuberculosis 
(TB) as a “global emergency” by the World 
Health Organization almost 20 years ago, 
TB still remain as a global problem in the 
world (Zhang et al.,2005). The latest estimates 
included  in this report are that there were  9.0 
million new TB cases in 2013 and 1.5 million 
TB deaths (WHO, 2014). The increased  of HIV 
cases and low socioeconomic status greatly 
influenced the development of TB (Rattan 
et al., 1999; Dye, 2006). Another obstacle in 
overcoming TB problem is the emergence 
of M.tuberculosis mutant that is resistant to 
anti TB drugs. The emergence of resistant 
strain is caused by lengthy therapy of at least 
six months makes patient uncompliance, 
so have inadequate treatment, then induce 
changes in bacterial properties which in turn 
become resistant to anti TB drugs. The WHO 
reported the frequency of  drug-resistant strains 
M.tuberculosis  ranging from 3 to 41% among 72 
countries. The current problems are the emerge 
of multi drug resistant TB (MDR-TB), which is 
resistant to isoniazid (INH)  and rifampicin, and 
extreme drug resistant TB (XDR-TB). The XDR-
TB strain is MDR with additional  resistant to 
one of fl uoroquinolones, and one or more of 
injectable drugs, such as kanamycin, amikacin, 
and capreomycin. MDR-TB and XDR-TB 
caused several fatal outbreaks worldwide 
(WHO, 2009). INH  is one of effective anti TB 
drugs with minimal inhibitory concentration 
(MIC) of 0.2-0.06 mg/L, nevertheless the rate 
of resistance to this drug is increasing ( WHO 
&IUATLD, 2004). INHpro-drug which is highly 
dependent on KatG to become reactive radical 
that attack target in M.tuberculosis cell.
Until date, INH along with rifampicin 
are backbones  of TB treatment. INH had 
been used as fi rst line anti TB medicine since 
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1952 to combat TB. There was a postulate 
stated that INH was an active pro drug after 
transforming by catalase peroxidase (KatG) 
became isonicotinate acid, and this change 
produced radicals that could interact with 
a main target within a mycobacterial cell 
(Musser, 1995; Heym et al.,1996; Bardou et 
al., 1998).
M.tuberculosis primary resistance 
towards INH emerged in the laboratory with 
estimated frequency of 10-5 - 10-7 that was 
higher than rifampicin. It was known that 
M.tuberculosis resistance towards INH was 
mostly related with mutation that involved 
1 or 2 genes namely katG, inhA and ahpC 
(Heym et al., 1997; Talenti et al., 1997; Morlock 
et al., 2003).
katG encodes catalase peroxide enzyme 
(KatG). This enzyme had a multiple function 
as a catalase and peroxidase with a wide 
specifi cation. Along with a catalyst reaction 
and enzyme peroxide, it functioned to free 
peroxide hydrogen from a biological system 
to protect bacterial cells from damages 
by reactive peroxides that produced by 
macrophage. Peroxidase has important roles 
in INH activation.
It was reported that 20-80% of INH 
resistant M.tuberculosis associated with katG 
mutation, and the frequency was related to 
geographical region of clinical isolate origin. 
Among katG mutation, Ser315Thr mutation 
contributes to 50-93% of INH resistant 
M. tuberculosis clinical isolates (Zhang et 
al.,2005).
Mutation of katG is the main resistance 
mechanism of INH, and mutation on codon 
315 (Ser315Thr) is the most frequently 
documented. This mutation responsible 
to the increasing of MIC as of 200 times 
compared to that of  H37Rv M.tuberculosis. 
This mutation is strongly associated with 
MDR mutant and transmitted easily among 
M. tuberculosis strain. Mutation may result 
in decrease activity of catalase-peroxidase 
and deletion of this gene may cause loss of 
the enzyme activity ( Mokrousov, 2002; Xue-
qiong et al., 2006; Hu et al., 2010).
It is important to analyze the pattern of 
resistance of katG Ser315Thr M.tuberculosis 
mutant to first line anti TB drugs. This 
study aimed to describe the pattern of anti 
TB drugs resistant among katG Ser315Thr 
M.tuberculosis mutant.
Material and Methods 
M. tuberculosis isolates.
M. tuberculosis clinical isolates are archive 
strains of Microbiology Laboratory, Faculty 
of Medicine, Universitas  Gadjah Mada. 
M.tuberculosis were cultured, identifi ed, and 
continued by katG mutation detection.  katG 
Ser315Thr mutant of M.tuberculosis  were 
tested  for  its sensitivity towards anti TB 
drugs.
M. tuberculosis identifi cation. 
M.tuberculosis   were cultured on 
Lowenstein Jensen (LJ) medium,  and 
incubated at 37°C for 3-4 weeks, with weekly 
observation. M. tuberculosis was identifi ed 
based on the colony morphology, Ziehl 
Nielsen staining, Niacin test and PNB test. 
M.tuberculosis on LJ medium developed a 
creamy colored colony with dry and rough 
consistence, grew slowly, did not grow 
on PNB supplemented LJ Medium, and 
positively reacted to Niacin.(Vestal, 1981)
Antimicrobial susceptibility test.  
Antimicrobial susceptibility test was 
performed by using modified indirect 
proportional on LJ medium. Each sample 
was cultured on a series of LJ medium 
containing fi rst line anti tuberculosis drugs; 
Streptomycin (4mg/L), INH (0.2 mg/L 
and 1.0 mg/L),  Ethambutol (2 mg/L), and 
Rifampicin (40 mg/L). Specimen was also 
cultured on LJ medium without drug and 
served as control. Inoculated media were 
incubated at 37 C for 3 weeks. Confluent 
growth on control was considered as 100 % 
growth. Sensitive or resistant determination 
was based on comparison between growth 
on medium with and without drug. An 
strain was considered resistant if the colonies 
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reach 1% of colony count on control medium 
(Vestal, 1981).
DNA isolation 
M. tuberculosis DNA isolation was 
carried out with boiling method according 
to Herrera et al. (2004). M. tuberculosis 
were scrapped from LJ and placed in tube 
containing 500 μL of sterile aquadest and 
heated at 95 C for 5 minutes. Samples were 
then spinned at 12.000 X g for 5 minutes, 
supernatants were saved and used as DNA 
template.
Mutation analysis of katG Ser315Thr (AGC 
> ACC)  
M u t a t i o n  d e t e c t i o n  w a s 
p e r f o r m e d  b y  u s i n g  P C R - R F L P 
method. One set of primers katG IF (5’-
AGCTCGTATGGCACCGGAAC) and katG 
4R (5’-AACGGGTCCGGGATGGTG-3’) were 
used for katG fragment amplifi cation (position 
904 to 1103 in H37Rv) (Mokrousov, 2002). 
Amplified fragments were digested with 
MspI. Briefl y, 15 μL PCR product was added 
with 10 μL of buffer and 2.7 μL of the enzyme. 
The mixtures were incubated in waterbath 
at  37°C for 8-16 hours. Digested fragments 
and marker V (Roche) were subjected to 4 % 
agarose gel electrophoresis and results were 
visualized with UV light. Mutated codon 
315 will be digested by MspI, resulting in 7 
fragments ; 14, 6, 21, 6, 11, 10, and 132 bps. 
Digestion of non mutant katG Ser315Thr 
resulted in 6 fragments; 14 , 6, 6,11,10, and 153 
bps (adapted from  Mokrousov et al., 2002). 
The PCR-RFLP analysis was confi rmed with 
DNA sequencing analysis.
Results and Discussion
Ser315Thr mutant of  M.tuberculosis 
isolates
In  this  s tudy 85  INH-res is tant 
M.tuberculosis isolates were obtained. Ten 
INH-sensitive isolates, which were culture 
collection from Laboratory of Microbiology, 
Faculty of Medicine Gadjah Mada university, 
were also included in the study. PCR-
RFLP procedures were performed for 
85 M. tuberculosis clinical isolates. The 
representative electrophoresis of PCR-RFLP 
procedure was showed in Figure 1. 
DNA sequence analysis was performed 
to confi rm the PCR-RFLP results for randomly 
selected eight M. tuberculosis isolates (7 mutants 
and 1 standard strain of H37Rv) (Fig 2). 
Overall mutation on katG Ser315Thr 
of M.tuberculosis among INH resistant 
Figure 1.  PCR-RFLP analysis result. PCR amplifi cation of katG gene segment produced 
199 bp bands.  PCR products were digested by using MspI restriction ezyme. After 
digestion, mutant katG Ser315 Thr produced 132bp fragment while non mutant 
produced 153bp fragment.
 
A 
B 
153
132 
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strain were relatively low (27,05%). It was 
reported that mutation on katG 315 codon 
in M. tuberculosis clinical isolates was most 
frequently found (50%-90%), the remaining 
mutations occurred in other loci ( Musser, 
1995; van Solingen et al., 2000; Mokrousov et 
al., 2004) It was suggested that  mutation in 
this codon is benefi cial for the bacteria, since 
it can reduce INH activity without removing 
catalase peroxidase activity that serve as 
virulance factor.
The results indicated that mutation 
katG315T may responsible for the phenotypic 
of INH resistance in index strains. The 
mutation only occur in INH resistant isolates, 
but not in INH sensitive isolates. 
Susceptibility of katGSer315Thr mutants 
to anti TB drugs 
Table 2 showed that the highest 
proportion of resistance in katGSer315Thr 
mutant was to three drugs (INH, rifampicin, 
and streptomycin). In non mutant isolates 
the highest frequency found was single drug 
resistance against INH. Among 23 mutant 
isolates, 14 (60.1 %) isolates were resistant 
Figure 2. DNA Sequencing result of codon 315 katG M.tuberculosis (reverse primer ) A :  DNA fragment 
of  representative mutant M. tuberculosis with ACC at codon 315, B :  DNA fragment of H37Rv strain at 
the same position showed  AGC 
A 
B 
 
Table 1.  The Frequency of  katG Ser315Thr M.tuberculosis mutant among the samples and the resistency to 
INH 
M. tuberculosis Resistant to INH Sensitive to INH No Sensitivity, Specifi city  PPV, NPV (%)
Mutant 23 (27,06%) 0 (0%) 23 Sensitivity :   27,05 
Specifi city   : 100,0
Non mutant 62 ( 72,94%) 10 (100%) 72  PPV             : 100,0          
Total   85 (100,00%) 10 (100%) 95 NPV            :  13,88
PPV= Positive Predictive Value, NPV =Negative Predictive Value
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to at least INH and rifampin, which was 
categorized as MDR isolates. Of 62 non 
mutant isolates, 19 (36.5 %) were MDR (data 
not shown).
Table 2 and 3 showed the difference 
of single drug resistant frequency among 
katG Ser315Thr mutant and non mutant. 
katG Ser315Thr mutant tend to resistant 
against more than 1 anti tuberculo sis drugs. 
It was noted that in the mutant group the 
MDR-TB (at least resistant against INH and 
Rifampicin) frequency is higher (60.85%) 
compare to 31.6% in the non mutant group. 
The katG  Ser315Thr mutant  M. 
tuberculosis predominantly resistant against 
3 fist line drugs, while katG Ser315Thr 
non mutant M. tuberculosis predominantly 
resisntant against single drugs (INH). 
This observation was in accordance to the 
previous report, 60.1 % of katG Ser315Thr 
mutant were MDR-TB, whereas only 36.5% 
MDR-TB were reported in non mutant 
(Hasbon et al., 2006). 
There are two hypothetical theories 
concerning the association between mutation 
on katG and INH resistant mechanism. 
Mutation on katG315 plays important role in 
the emergence of secondary resistance after 
development of primary resistance. Mutation 
on katG occurs after the isolates become 
MDR. The other hypothesis stated that 
mutation on katG315 causes isolates become 
more resistant, more easily transmissible, and 
develop to MDR (Zhang et al., 2005).
Hazbon suggested that resistance to 
INH and evolution of MDR strains is very 
complex and dynamic, involving various 
genes interaction  and anti TB drug resistace 
phenotype ( Hazbon et al.,2006; Bulatovic 
et al., 2002; Van Solingen et al., 2000). More 
extensive studies are needed to be able to 
explain mechanism of resistance to anti TB 
drugs. It is also important to develop new 
molecular-based diagnostic method (Zhang 
et al., 2005).
Resistance to INH has been associated 
with deletion or point mutation on katG gene 
in which serine is replaced with threonin 
at position 315 (Ser315Thr). Substitution of 
ser-315 is one of the most frequent mode in 
clinical isolates with resistance to INH (Van 
Solingen et al., 2000;  Luo  et al., 2010; Jagielski 
et al., 2013). Minimal inhibitory concentration 
of INH resistant isolates increase 20-200 times. 
With position of cytochrome oxidase super 
family peroxidase-catalase, it is suggested 
that Ser315 is close to active site of KatG so 
that Ser315Thr mutation infl uence enzyme 
activity of KatG (Heym et al., 1998; Bulatovic 
et al., 2002; Van Solingen et al., 2000.; Luo et 
al., 2013).
Our results showed that katGSer315Thr 
mutation was frequently (27.06%) found in 
the INH resistant M. tuberculosis that may 
responsible for the multi resistant against 
anti tuberculosis drugs. 
  
Table 2. Susceptibility of katG Ser315Thr M.tuberculosis mutant and non mutant  against anti tuberculosis 
drugs. 
M. tuberculosis n
Resistant to Anti Tuberculosis Drugs
I I + R I + E I + R + S I + S + E I + R + S + E
katG Ser315Thr Non mutant   62 30 13 13 5 0 1
katG Ser315Thr Mutant 23 4 4 4 10 1 0
Note: I;  INH  R: rifampicin; S: streptomycin; E: ethambutol
Table. 3 Susceptibility of katG Ser315Thr mutant and katG Ser315Thr non mutant against INH
 M. tuberculosis n Resistant to more than one drug (%) Resistant toINH (%)
 katG Ser315Thr non mutant
katG Ser315Thr mutant
62
23
32  (51.61)
19 (82.61)
30 (48.39)
4 (17.40)
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